Illinois Tool Works

ITW · NYSE

$274.97+$4.80 (+1.78%)TodayMarket closed · Oct 20, 7:45 PM ET

Prev close $270.17

ITW analyst rating

HoldConsensus of 9 analysts over the last 12 months. 11% rate it a buy.

Strong buy0
Buy1
Hold5
Underperform2
Sell1

12-month price target · 16 analysts

Average $297.36 (+8.1% upside)

Low: $225.61
Now: $274.97
High: $336.00

Upgrades and downgrades

The latest rating actions, newest first

ITW analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
JP Morgan	Oct 9, 2026	Downgrade	Overweight → Neutral	$350.00 → $277.00	65%
Truist Securities	Oct 5, 2026	Maintains	Hold	$308.00 → $297.00	59%
Evercore ISI Group	Aug 11, 2026	Maintains	Underperform	$272.00 → $309.00	64%
JP Morgan	Jul 29, 2026	Maintains	Overweight	$310.00 → $350.00	53%
Baird	Jul 29, 2026	Maintains	Neutral	$278.00 → $297.00	30%
JP Morgan	Jul 13, 2026	Maintains	Overweight	$295.00 → $310.00	53%
Truist Securities	Jul 2, 2026	Maintains	Hold	$280.00 → $301.00	59%
Wells Fargo	May 4, 2026	Maintains	Underweight	$245.00 → $255.00	51%
Citigroup	May 4, 2026	Maintains	Neutral	$284.00 → $287.00	63%
JP Morgan	May 1, 2026	Maintains	Overweight	$303.00 → $295.00	53%

The case for and against

Updated Oct 19, 2025

Bull case

Illinois Tool Works (ITW) demonstrates a solid financial outlook, driven by a projected operating income of approximately $4.33 billion with an anticipated operating margin improvement to 26.5-27.5%, indicating a 100 basis points year-over-year growth at the midpoint. The company has experienced momentum in its electronics and aerospace sectors, with equipment orders increasing by double digits, which is expected to contribute positively to overall margin growth across all segments. Furthermore, ITW's operating income of $135 million and a notable operating margin of 30.9%, up 120 basis points year-over-year, further highlight the company's effective execution of enterprise initiatives, reinforcing its resilient market position.

Bear case

Illinois Tool Works demonstrated a decline in operating income, with a significant operating margin drop to 21.4%, reflecting a negative operating leverage effect and increased restructuring costs. The specialty products segment saw a decrease in sales by 1% year-over-year, alongside a notable drop in organic growth compared to the previous year, highlighting ongoing revenue challenges. Additionally, the automotive OEM segment experienced a decline in organic growth of 1% due to substantial weaknesses in North America and Europe, raising concerns about the company's overall growth trajectory.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.